A detailed history of Avantax Advisory Services, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 897 shares of MEDP stock, worth $300,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares
897
Previous 807 11.15%
Holding current value
$300,629
Previous $332,000 9.94%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$320.58 - $457.29 $28,852 - $41,156
90 Added 11.15%
897 $299,000
Q2 2024

Aug 09, 2024

BUY
$372.0 - $424.34 $300,204 - $342,442
807 New
807 $332,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.